Regulators are intensifying their scrutiny of artificial intelligence, with the Federal Trade Commission demanding information from major AI firms on children’s safety measures. Meanwhile, a federal pilot program set to use AI to authorize Medicare treatments in six states is drawing fire from lawmakers who fear it could lead to wrongful denials of care.